Navigation Links
Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment
Date:7/8/2009

tients were enrolled at approximately 30 centers throughout the United States. The primary efficacy endpoint is the change from baseline in pain intensity as measured by a Visual Analog Scale (VAS) during daily activities over the past 24 hours at Day 3.

Transdel Pharmaceuticals is seeking a partner for Ketotransdel and is either in or pursuing discussions with U.S. and foreign based potential partners with sales and marketing infrastructures to support Ketotransdel in the event that the product is approved and commercialized.

About Transdel Pharmaceuticals, Inc.

Transdel Pharmaceuticals, Inc. (OTCBB: TDLP) is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company's innovative-patented Transdel(TM) cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel(R), the Company's lead pain product, utilizes the Transdel(TM) technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug ("NSAID"), through the skin directly into the underlying tissues where the drug exerts its well-known anti-inflammatory and analgesic effects. The Company intends to leverage its Transdel(TM) platform technology to expand and create a portfolio of topical products for a variety of indications. The Company is actively pursuing partnerships with companies to expand its product portfolio for pharmaceutical and cosmetic/cosmeceutical products. The Company recently announced that they entered into a license agreement with JH Direct, LLC for the exclusive worldwide rights to Transdel's anti-cellulite cosmeceutical product which utilizes the Company's Transdel(TM) technology. For more information, please visit http://www.transdelpharma.com.'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Transdel Pharmaceuticals Provides Update on Timing of Results for Phase 3 Study
2. Transdel Pharmaceuticals Enters Into License Agreement with JH Direct, LLC for Cosmeceutical Product
3. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
4. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
5. Transdel Expands Program to Include Cosmetic/Cosmeceutical Products
6. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
7. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
8. Arena Pharmaceuticals Announces Public Offering of Common Stock
9. Solvay Pharmaceuticals, Inc. Announces Commercial Availability of CREON(R) (Pancrelipase) Delayed-Release Capsules
10. Jazz Pharmaceuticals Pays Accrued Interest Under Senior Secured Notes
11. Jazz Pharmaceuticals Completes $7 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... ... providers, has been retained to lead a national chief executive officer recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/2/2015)... ... July 02, 2015 , ... After conducting a nationwide executive search ... Center in Yuma, Ariz., has hired Robert Trenschel, DO, as chief executive officer. ... Dr. Trenschel will assume his new duties at Yuma Regional Medical Center on July ...
(Date:7/2/2015)... ... July 02, 2015 , ... The ... Gelatin Capsule manufacturers. The report is a valuable source of guidance and direction ... global and Chinese market for the Gelatin Capsule industry including capacity, production, production ...
(Date:7/2/2015)... ... July 02, 2015 , ... Evolved Ayurvedic ... their launch an intention to partner with companies that share a similar mission ... Their innovative water soluble, Cannabidiol (CBD) formulations, combined with Ayurvedic herbs, are now ...
(Date:7/2/2015)... ... July 02, 2015 , ... Every year, DUI arrests and fatalities spike on the 4th of ... day of the year when it comes to being on the road. According to attorney ... Association reports that 40% of all highway deaths between 2007 and 2011 were caused by ...
Breaking Medicine News(10 mins):Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:Attorney David Maloney Stresses Safety through Sobriety 2
... , FRIDAY, June 24 (HealthDay News) -- Dieting ... young adulthood, a new study finds. Disordered eating includes ... meals and binge eating. Researchers analyzed ... for 10 years beginning in either early adolescence (about 13 ...
... the lung-damaging effects of traffic-related pollution (TRP) in children, ... Medicine of the University of Southern California (USC) in ... of the print edition of the American Thoracic Society,s ... . "This is the first study demonstrating that ...
... A group of 26 of the nation,s leaders in medicine, ... changes in the design, supervision and financing of U.S. hospital ... errors, and end dangerously long work hours for physicians ... the June 24 issue of the online journal Nature & ...
... with chronic obstructive pulmonary disease (COPD) who use inhaled ... have a 27 percent increased risk of bone fractures, ... subjects were mostly men age 60 and older, the ... effects on women with COPD, a group already at ...
... have found a likely explanation for the slow growth of ... tests on a new cell-based model of the tumor, they ... a growth-braking tumor-suppressor gene, in a process similar to that ... June 1 issue of Clinical Cancer Research , could ...
... SUWON, KOREAFormaldehyde is a major contaminant of indoor ... paper products, tobacco smoke, and other sources. Indoor ... contribute to allergies, asthma, headaches, and a condition ... widespread; a 2002 report from the World Health ...
Cached Medicine News:Health News:Extreme Dieting Often Lasts From Early Teens to Adulthood 2Health News:Exposure to parental stress increases pollution-related lung damage in children 2Health News:Experts seek reforms to prevent errors from medical resident fatigue, lack of supervision 2Health News:Experts seek reforms to prevent errors from medical resident fatigue, lack of supervision 3Health News:Experts seek reforms to prevent errors from medical resident fatigue, lack of supervision 4Health News:Study: Long-term inhaled corticosteroid use increases fracture risk in lung disease patients 2Health News:Slow growth of childhood brain tumors linked to genetic process seen in skin moles 2Health News:Study of phytoremediation benefits of 86 indoor plants published 2
(Date:7/2/2015)... , June 25, 2015 ... addition of the "Veterinary / Animal Vaccines Market ... 2020" report to their offering. The ... Million by 2020 from $5,507.3 Million in 2015, at ... Major factors fueling market growth are growing prevalence ...
(Date:7/2/2015)... 2015   Wilson Therapeutics AB , a privately-held ... to its board of directors. The appointment was approved ... June 30. "We are delighted to welcome ... Hansson , CEO of Wilson Therapeutics. "Hans brings significant ... forward to his contributions to the Company." ...
(Date:7/1/2015)... DUBLIN , July 1, 2015 Jazz Pharmaceuticals ... will be webcasting its corporate presentation at the Cantor Fitzgerald ... Russell Cox , executive ... of the company and a business and financial update on ... p.m. IST.  A live audio webcast of ...
Breaking Medicine Technology:Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2
... 21, 2011 Reportlinker.com announces that ... available in its catalogue: ... Manufacturing, Research and Packaging: Focus on ... REPORT HIGHLIGHTS ...
... 2011 Civic leaders today joined senior management from Isis ... Trust, Inc. (NYSE: BMR ) to celebrate the ... research facility on Gazelle Court in the Carlsbad Oaks North ... ceremony were Stanley T. Crooke, M.D., Ph.D., Chairman and Chief ...
Cached Medicine Technology:Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 2Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 3Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 4Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 5Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 6Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 7Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 8Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 9Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 10Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 11Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 12Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 13Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 14Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 15Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe 16Isis Pharmaceuticals and BioMed Realty Trust Celebrate Grand Opening of New R&D Facility in Carlsbad, California 2Isis Pharmaceuticals and BioMed Realty Trust Celebrate Grand Opening of New R&D Facility in Carlsbad, California 3Isis Pharmaceuticals and BioMed Realty Trust Celebrate Grand Opening of New R&D Facility in Carlsbad, California 4Isis Pharmaceuticals and BioMed Realty Trust Celebrate Grand Opening of New R&D Facility in Carlsbad, California 5
... Digital Flexible Ureteroscope (DUR-D) incorporates many ... proven durable, market leading DUR® series ... first device utilizing Gyrus ACMIs proprietary, ... Metal Oxide Semi-Conductor (CMOS) distal sensor ...
... is the first one-step 20 minutes rapid test ... 2 produced by Enterohemorrhagic Escherichia coli in human ... enrichment of fecal specimens and detects all Toxigenic ... separate result for Toxin 1 and 2 is ...
Inquire...
... elegant and sophisticated woman, the ... ophthalmic and sunwear styles. Frames ... of shapes and colors, designed ... and complexions. Many styles feature ...
Medicine Products: